☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
children
Alexion's Ultomiris (ravulizumab) Receives EC's Approval for Expanded Use to Treat Paroxysmal Nocturnal Haemoglobinuria
September 3, 2021
Sanofi and Regeneron's Dupixent Meets All Endpoints in P-III Study in Children with Atopic Dermatitis
August 30, 2021
Alexion's Ultomiris (ravulizumab) Receives CHMP's Positive Opinion Recommending its Approval for Children and Adolescents with PNH
July 26, 2021
Janssen Reports Submission of NDA to the US FDA for Xarelto (rivaroxaban) to Prevent and Treat Blood Clots in Children
June 24, 2021
J&J Vision Collaborates with Menicon to Offer Contact Lenses for Managing the Progression of Myopia in Children
April 7, 2021
The US FDA Approves New Indication and Formulation for Astellas' Myrbetriq
March 26, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.